Peptic esophagitis
MONDO:0006896Inflammation of the esophagus that is caused by the reflux of gastric juice with contents of the stomach and duodenum.
28 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New GERD drug shows promise in major trial
Disease control OngoingThis study tests a new medication, linaprazan glurate, to see if it heals esophagus damage from acid reflux better than a standard drug. About 500 adults with erosive esophagitis will take either the new drug or lansoprazole daily for up to 8 weeks. Doctors will use cameras to ch…
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can nexium keep Kids' esophagitis at bay? new study seeks answers
Disease control OngoingThis phase 3 study tests two doses of Nexium (esomeprazole) in 53 children aged 1 to 11 years who have erosive esophagitis, a condition where stomach acid damages the esophagus. The goal is to see which dose better maintains healing after an initial 8-week treatment period. Child…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New GERD drug aims to keep esophagus healed, but trial never started
Disease control TerminatedThis study was designed to see if a new drug called linaprazan glurate could keep the esophagus healed in people with GERD-related erosive esophagitis, compared to an existing drug (lansoprazole). Participants would have taken daily pills for up to 52 weeks and had regular camera…
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC